Carnegie has published a new commissioned research report initiating coverage on
To access the full report and subscribe to future updates, visit https://www.carnegie.se/en/commissioned-research/eql-pharma/
© Modular Finance, source
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
52.6 SEK | 0.00% | +5.62% | +57.49% |
May. 15 | Transcript : EQL Pharma AB, Q4 2024 Earnings Call, May 15, 2024 | |
May. 14 | EQL Pharma AB Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 | CI |
Carnegie has published a new commissioned research report initiating coverage on
To access the full report and subscribe to future updates, visit https://www.carnegie.se/en/commissioned-research/eql-pharma/
© Modular Finance, source
1st Jan change | Capi. | |
---|---|---|
+57.49% | 147M | |
-39.18% | 13.73B | |
-33.12% | 10.79B | |
+10.09% | 6.15B | |
-11.29% | 5.9B | |
+70.07% | 4.82B | |
-3.94% | 4.63B | |
-6.82% | 3.9B | |
-21.89% | 3.06B | |
-12.98% | 2.87B |